Whole-exome sequencing and genome-wide methylation analyses identify novel disease associated mutations and methylation patterns in idiopathic hypereosinophilic syndrome

Keyphrases

• Novel Disease 100%
• Disease-causing mutations 100%
• Hypereosinophilic Syndrome 100%
• Whole Exome Sequencing 100%
• Mutation Pattern 100%
• Methylation Pattern 100%
• Genome-wide Methylation Analysis 100%
• Pseudoeosinophilia 60%
• Eosinophilia 40%
• Differential Methylation 40%
• DNA Methylation Profiling 40%
• Missense mutation 20%
• Eosinophils 20%
• B Cells 20%
• Per Se 20%
• In Cancer 20%
• T Cells 20%
• Point mutation 20%
• Sampling Methods 20%
• Tumor Suppressor Gene 20%
• Hematological Diseases 20%
• Clonal Origin 20%
• Functional Pathways 20%
• Cancer Genes 20%
• Clinical Work 20%
• Cancer Cell Death 20%
• Platelet-derived Growth Factor Receptor (PDGFR) 20%
• Hypermethylated 20%
• Ingenuity Pathway Analysis 20%
• PUF60 20%
• Cancer Cell Survival 20%
• Molecular Aberrations 20%
• Differentially Methylated CpG Sites 20%
• CDH17 20%
• Spliceosome 20%
• Diagnostic Workup 20%
• Splice Site mutation 20%
• Cadherin Genes 20%

Biochemistry, Genetics and Molecular Biology

• DNA Methylation 100%
• Exome Sequencing 100%
• Spliceosome 100%
• Methylation Analysis 100%
• Methylation Pattern 100%
• Cell Death 50%
• Missense Mutation 50%
• Tumor Suppressor Gene 50%
• Cancer Cell 50%
• B Cell 50%
• T Cell 50%
• Cell Survival 50%
• Point Mutation 50%
• CpG Site 50%
• Tumor-Related Gene 50%
• Platelet Derived Growth Factor Receptor Alpha 50%
• Cadherin 50%